Orphan Drug Act

Oct 17, 2017

New Study Examines Use and Cost of Orphan Drugs

Oct 02, 2017

Stealth BioTherapeutics Granted Orphan Drug Designation of Elamipretide for Treatment of Patients with Primary Mitochondrial Myopathy

Aug 17, 2017

Leading Biotech Companies Receiving Orphan Drug Designation in 2017

Aug 09, 2017

Ocugen Receives FDA Orphan Drug Designation for OCU300 (brimonidine tartrate) for the Treatment of Ocular Graft Versus Host Disease

Aug 01, 2017

Sirnaomics Leading siRNA Therapeutic Candidate, STP705, Granted Orphan Designation for the Treatment of Primary Sclerosing Cholangitis (PSC)

Jul 28, 2017

Top Companies Receiving Orphan Drug Designation in 2017